BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36366527)

  • 1. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats.
    Cook S; Wittenburg L; Yan VC; Theil JH; Castillo D; Reagan KL; Williams S; Pham CD; Li C; Muller FL; Murphy BG
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of monotherapy and combined anticoronaviral therapies against feline coronavirus serotype II in vitro.
    Cook SE; Vogel H; Castillo D; Olsen M; Pedersen N; Murphy BG
    J Feline Med Surg; 2022 Oct; 24(10):943-953. PubMed ID: 34676775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNA replicon system to investigate promising inhibitors of feline coronavirus.
    Schmied K; Ehmann R; Kristen-Burmann C; Ebert N; Barut GT; Almeida L; Kelly JN; Thomann L; Stalder H; Lang R; Tekes G; Thiel V
    J Virol; 2024 Feb; 98(2):e0121623. PubMed ID: 38236006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of Full-Length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.
    Wang G; Hu G; Liang R; Shi J; Qiu X; Yang Y; Jiao Z; Chen Y; Shen Z; Li M; Shi Y; Mao J; Peng G
    J Virol; 2021 Oct; 95(21):e0074521. PubMed ID: 34406859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials.
    Murphy BG; Castillo D; Neely NE; Kol A; Brostoff T; Grant CK; Reagan KL
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority Study.
    Cosaro E; Pires J; Castillo D; Murphy BG; Reagan KL
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies.
    Murphy BG; Perron M; Murakami E; Bauer K; Park Y; Eckstrand C; Liepnieks M; Pedersen NC
    Vet Microbiol; 2018 Jun; 219():226-233. PubMed ID: 29778200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virus.
    Doki T; Takahashi K; Hasegawa N; Takano T
    Res Vet Sci; 2022 May; 144():27-33. PubMed ID: 35033848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of antiviral T cell responses during primary and secondary challenge of laboratory cats with feline infectious peritonitis virus (FIPV).
    Mustaffa-Kamal F; Liu H; Pedersen NC; Sparger EE
    BMC Vet Res; 2019 May; 15(1):165. PubMed ID: 31118053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing
    Coggins SJ; Kimble B; Malik R; Thompson MF; Norris JM; Govendir M
    Vet Q; 2024 Dec; 44(1):1-9. PubMed ID: 38288972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats.
    Izes AM; Yu J; Norris JM; Govendir M
    Vet Q; 2020 Dec; 40(1):322-330. PubMed ID: 33138721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis.
    Dickinson PJ; Bannasch M; Thomasy SM; Murthy VD; Vernau KM; Liepnieks M; Montgomery E; Knickelbein KE; Murphy B; Pedersen NC
    J Vet Intern Med; 2020 Jul; 34(4):1587-1593. PubMed ID: 32441826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping Feline Coronavirus Shedding Prevented Feline Infectious Peritonitis.
    Addie DD; Bellini F; Covell-Ritchie J; Crowe B; Curran S; Fosbery M; Hills S; Johnson E; Johnson C; Lloyd S; Jarrett O
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524.
    Green J; Syme H; Tayler S
    J Vet Intern Med; 2023; 37(5):1784-1793. PubMed ID: 37403259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of a real-time reverse transcriptase polymerase chain reaction detecting feline coronavirus mutations in effusion and serum/plasma of cats to diagnose feline infectious peritonitis.
    Felten S; Leutenegger CM; Balzer HJ; Pantchev N; Matiasek K; Wess G; Egberink H; Hartmann K
    BMC Vet Res; 2017 Aug; 13(1):228. PubMed ID: 28768514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
    Jiao Z; Yan Y; Chen Y; Wang G; Wang X; Li L; Yang M; Hu X; Guo Y; Shi Y; Peng G
    J Virol; 2022 Sep; 96(17):e0090722. PubMed ID: 36000844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524.
    Coggins SJ; Norris JM; Malik R; Govendir M; Hall EJ; Kimble B; Thompson MF
    J Vet Intern Med; 2023; 37(5):1772-1783. PubMed ID: 37439383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outbreak of feline infectious peritonitis in a Taiwanese shelter: epidemiologic and molecular evidence for horizontal transmission of a novel type II feline coronavirus.
    Wang YT; Su BL; Hsieh LE; Chueh LL
    Vet Res; 2013 Jul; 44(1):57. PubMed ID: 23865689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro.
    McDonagh P; Sheehy PA; Norris JM
    Vet Microbiol; 2015 Mar; 176(1-2):10-8. PubMed ID: 25596968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.